In addition, high levels of anti-DSG2 autoantibodies correlated with a higher burden of premature ventricular contractions in ARVC patients (Chatterjee et al. 2018), altogether highlighting their potential as inflammatory biomarkers in ARVC. Here, DSG2 is linked to arrhythmogenic right ventricular cardiomyopathy.